Alhamad, Tarek, Murad, Haris, Dadhania, Darshana M., Pavlakis, Martha, Parajuli, Sandesh, Concepcion, Beatrice P., Singh, Neeraj, Murakami, Naoka, Casey, Michael J., Ji, Mengmeng, Lubetzky, Michelle, Tantisattamo, Ekamol, Alomar, Omar, Faravardeh, Arman, Blosser, Christopher D., Basu, Arpita, Gupta, Gaurav, Adler, Joel T., Adey, Deborah, and Woodside, Kenneth J.
The management of failing kidney allograft and transition of care to general nephrologists (GN) remain a complex process. The Kidney Pancreas Community of Practice (KPCOP) Failing Allograft Workgroup designed and distributed a survey to GN between May and September 2021. Participants were invited via mail and email invitations. There were 103 respondents with primarily adult nephrology practices, of whom 41% had an academic affiliation. More than 60% reported listing for a second kidney as the most important concern in caring for patients with a failing allograft, followed by immunosuppression management (46%) and risk of mortality (38%), while resistant anemia was considered less of a concern. For the initial approach to immunosuppression reduction, 60% stop antimetabolites first, and 26% defer to the transplant nephrologist. Communicating with transplant centers about immunosuppression cessation was reported to occur always by 60%, and sometimes by 29%, while 12% reported making the decision independently. Nephrologists with academic appointments communicate with transplant providers more than private nephrologists (74% vs. 49%, p = 0.015). There are heterogeneous approaches to the care of patients with a failing allograft. Efforts to strengthen transitions of care and to develop practical practice guidelines are needed to improve the outcomes of this vulnerable population. [ABSTRACT FROM AUTHOR]